Agilent Technologies Inc
SWB:AG8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Agilent Technologies Inc
SWB:AG8
|
US |
|
Apple Inc
NASDAQ:AAPL
|
US |
|
H
|
Heartflow Inc
NASDAQ:HTFL
|
US |
Intrinsic Value
The intrinsic value of 
Agilent Technologies Inc (AG8) under the Base Case is 131.39 EUR per share.
Compared with the current market price of 155 EUR, the stock appears
Overvalued by 15% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Agilent Technologies Does
Agilent Technologies makes the tools that scientists and lab technicians use to test, measure, and analyze samples. Its products include analytical instruments, lab software, consumables, and repair and support services. Customers use them in drug development, clinical and diagnostic labs, food safety, environmental testing, and chemical research.
- Headquarters
- United States of America US
- Employees
- 18 000
- IPO date
- Nov 18, 1999
Agilent Technologies has a wide economic moat
Replacing Agilent equipment and software can mean retraining staff, transferring testing methods and proving that results remain reliable, making a cheaper rival costly to adopt. Regulatory approvals for its cancer tests create another barrier, because competitors must establish that their own tests are suitable for the same treatment decisions.
Read the full moat analysis
Revenue & Expenses Breakdown
Agilent Technologies Inc
Earnings Waterfall
Agilent Technologies Inc
The intrinsic value for Agilent Technologies Inc (AG8) under the Base Case is 131.39 EUR.
Compared with the current market price of 155 EUR, the stock appears Overvalued by 15% .